Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasterCard Inc (MA) vs Medpace Holdings Inc (MEDP) Price & Performance

MasterCard IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

MasterCard Inc vs Medpace Holdings Inc — how do they compare? MasterCard Inc trades at $558.62 (market cap $491.83B), while Medpace Holdings Inc trades at $601.56 (market cap $16.90B). The key difference: MasterCard Inc is far larger — about 29.1× Medpace Holdings Inc's market cap, and MasterCard Inc pays a 0.62% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

MAMEDP
Market Cap
$491.83B$16.90B
Volume
4,635,698
Sector
Consumer CyclicalTechnology
52-Week High
$598.96$620.59
52-Week Low
$471.55$393.42
Enterprise Value
$504.86B$16.52B
Dividend Yield
0.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MasterCard Inc

Mastercard (MA) trades at $563.17, showing stability with a slight 0.04% daily gain. The stock exhibits strong fundamentals, with Q2 2026 EPS beating expectations at $5.04 versus $4.77, and maintains robust profitability with a 46.34% net income margin. Technical indicators signal a bullish trend, supported by moving averages, while analyst consensus is overwhelmingly positive with a $660.85 price target. Recent news highlights institutional acquisitions and strategic initiatives in AI and digital inclusion.

Outlook remains favorable driven by consistent earnings beats and revenue growth, though risks include competitive pressures from emerging payment technologies like stablecoins and high valuation multiples. The stock presents a growth opportunity with solid institutional backing, but investors should monitor execution on innovation and macroeconomic factors affecting consumer spending.

Medpace Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MasterCard Inc

Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.

Read more on MA

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP